XML 39 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Acquisitions (Tables)
12 Months Ended
Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]  
Schedule of Fair Value of the Assets Acquired and Liabilities Assumed
The table below summarizes the fair value of identifiable assets acquired and liabilities assumed in the Acquisition and the revisions made in 2022:
(in thousands)October 22, 2021RevisionsDecember 31, 2022
Cash and cash equivalents$1,533 $1,533 
Accounts receivable, net of allowance for credit losses of $118
5,358 5,358 
Inventories, net1,561 1,561 
Prepaid expenses and other current assets454 454 
Property, plant and equipment, net15,697 $1,594 17,291 
Right of use asset, operating leases, net208 208 
Intangible assets, net5,750 5,750 
Total identifiable assets acquired30,561 1,594 32,155 
Accounts payable1,751 1,751 
Accrued expenses and other current liabilities1,622 1,622 
Current portion of operating lease liabilities51 51 
Current portion of finance lease liabilities215 215 
Deferred income taxes2,542 346 2,888 
Long-term portion of operating lease liabilities157 157 
Long-term portion of finance lease liabilities1,408 1,408 
Total identifiable liabilities assumed7,746 346 8,092 
Net identifiable assets acquired22,815 1,248 24,063 
Transaction price34,097 34,097 
Goodwill$11,282 $(1,248)$10,034 
Schedule of Business Acquisitions, by Acquisition
Total net sales and operating income for DanChem for the period from October 22, 2021 through December 31, 2022 were as follows:

(in thousands)2022Period from
10/22/2021 - 12/31/2021
Net sales$32,297 $5,692 
Operating income$115 $621 
Schedule of Unaudited Pro Forma Financial Information
The following unaudited consolidated pro forma summary has been prepared by adjusting the Company's historical data to give effect to the acquisition of DanChem as if it had occurred on January 1, 2021:
(unaudited)Year Ended December 31, 2021
(in thousands, except per share data)
Net sales $358,735 
Net income21,681 
Basic net income per common share2.32 
Diluted net income per common share$2.29